Ticker Symbol: MRUS
Merus N.V
$28.65 - 20-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Netherlands
Currency:
USD
Asset
Type: Common Stock
CIK:0001651311
Company Profile
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Yalelaan 62
Website: www.merus.nl
CEO: Sven Lundberg
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $21.09
Change:
-$1.40
(
-6.22%)
Days Range: $20.55 - $22.59
Beta: 0.94
52wk. High: $27.70
52wk. Low: $12.03
Ytd. Change 39.15%
50 Day Moving Average: $22.95
200 Day Moving Average: $22.95
Shares Outstanding: 49859488
Valuation
Market Cap: 105.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A